Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McDevitt

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Nature Communications|April 26, 2018
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancerMichael R McDevitt, Daniel L J Thorek, Takeshi Hashimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2021
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman PrimatesDarren R Veach, Claire M Storey, Katharina Lückerath, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Nature Communications|April 26, 2018
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancerMichael R McDevitt, Daniel L J Thorek, Takeshi Hashimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2021
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman PrimatesDarren R Veach, Claire M Storey, Katharina Lückerath, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Pageof 12